Navigation Links
CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation
Date:1/4/2008

SAN DIEGO, Jan. 4 /PRNewswire-FirstCall/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today the publication of a European study of atrial fibrillation patients treated with CryoCor's Cardiac Cryoablation System. The purpose of the study was to evaluate the role of atrial flutter in the recurrence of atrial fibrillation and the effectiveness of an ablation strategy focused on isolating the pulmonary veins to treat the atrial fibrillation. The study was published in the December 11, 2007 issue of Circulation.

The 98-patient study was conducted by Dr. Wendel Moreira, Dr. Luz-Maria Rodriguez, Dr. Carl Timmermans and others in Academic Hospital Maastricht using CryoCor's Cardiac Cryoablation System. The study prospectively evaluated the best catheter ablation strategy in patients with paroxysmal atrial fibrillation with and without concomitant right atrial flutter. During follow-up averaging 26 months, the authors found that electrical isolation of the pulmonary veins by catheter ablation was successful in patients without concomitant atrial flutter at an 82% success rate. In patients with concomitant atrial flutter, the combination of ablation for atrial flutter and pulmonary vein isolation alone to treat atrial fibrillation was frequently insufficient in preventing recurrences of atrial fibrillation (recurrence rate of 67%). The authors concluded that those patients with atrial flutter and atrial fibrillation may require additional sites of ablation to effectively treat their atrial fibrillation.

Dr. Rodriguez, senior author of the study, stated, "This is the first time that an ablation strategy for paroxysmal atrial filbrillation and atrial flutter has been systematically studied. This has implications for the tools that a clinician may use to treat these atrial arrhythmias. Based on this study, we do not believe that it will be sufficient to simply isolate the pulmonary veins
'/>"/>

SOURCE CryoCor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. CryoCor Files Response to Patent Infringement Lawsuit
2. CryoCor Announces Web cast and Conference Call of Third Quarter 2007 Results
3. CryoCor Appoints New Vice President of Sales and Marketing
4. CryoCor to Present at Maxim Group First Annual Growth Conference in New York
5. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
6. FDA Reports New Risks Posed by Anemia Drugs
7. Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement
8. UCI Medical Affiliates, Inc. Reports Fiscal Year End Results for September 30, 2007
9. The Ensign Group, Inc. Reports Third Quarter 2007 Earnings
10. HealthPartners Reports 2007 Most Cost Effective Programs Reduce Expenses by $74 Million
11. Par Pharmaceutical Reports Third-Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... study provides welcome news for patients with a common ... The condition is estimated to impact 62,000 Canadians and ... clot forms in a vein and restricts the flow ... the clot may detach from its point of origin ... a potentially fatal condition known as a pulmonary embolism. ...
(Date:12/5/2009)... significant scientific advances in the field of blood cancers, ... of how certain diseases progress in order to discover ... care. Research presented today at the 51st Annual Meeting ... therapies for managing multiple myeloma, the importance of advance ...
(Date:12/5/2009)... experts advise , , SATURDAY, Dec. 5 (HealthDay News) -- ... can have bad reactions to certain holiday traditions and ... wheezing, according to the American College of Allergy, Asthma ... live evergreens may choose to decorate with artificial plants, ...
(Date:12/5/2009)... Wind Turbines are popping up in the most unusual places, and to ... , ... (PRWEB) December 5, 2009 -- Who would have thought that ... Inc. of Fort Worth, Texas has announced a new line of turbines, ...
(Date:12/4/2009)... PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, ... Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, ... presenting at the 2009,Goldman Sachs U.S. Financial Services Conference ... York City on Tuesday, December 8, 2009. ,, ...
Breaking Medicine News(10 mins):Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
... Cold and Compression Product for Hands Helps Improve Healing, Reduce ... ... 6 Game Ready(TM) announced today,the release of its breakthrough ... injury treatment system. The Hand Wrap,dramatically increases physicians, and patients, ...
... Trend Analysis and Survey Findings Disclosed at Nov. ... the past quarter experiencing,unprecedented market ups and downs, ... overall spending. As a,result, emerging compensation trends in ... for performance," as well as enhanced discussion,and scrutiny ...
... YORK, Nov. 6 HMS Holdings Corp. (Nasdaq:,HMSY) today ... Annual,Global Healthcare Conference, which will be held November 12-14, ... Robert Holster, CEO and Walter Hosp, CFO, will present ... Holdings Corp. (Nasdaq: HMSY ) is the nation,s ...
... Come True, to Manassas Man Seeking to,Improve His Mobility, ... 20 years with the Fairfax County Police Department as a,"blessing" ... arthritis in his knees and a bad back, Mr. Yeepun ... blessing.", Mr. Yeepun proudly recalls his years as a ...
... 6 /Xinhua-PRNewswire/ --,Synutra International, Inc. (Nasdaq: SYUT; "Synutra"), ... in China, today provided a,progress update on its ... its second quarter ended September 30, 2008., ... completed the recall of all 8 lots of ...
... But Overall Failing Grades, WASHINGTON, Nov. 6 ... (LCA) marked the start of Lung Cancer Awareness,Month with ... a national,assessment of progress being made in the fight ... overall, failing grades continued., (Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO ), ...
Other Medicine News:Health News:Game Ready(TM) Announces New Hand Treatment 2Health News:2008 Compensation and Entrepreneurship Report Highlights Executive Compensation Trends at Emerging Life Sciences Firms 2Health News:2008 Compensation and Entrepreneurship Report Highlights Executive Compensation Trends at Emerging Life Sciences Firms 3Health News:2008 Compensation and Entrepreneurship Report Highlights Executive Compensation Trends at Emerging Life Sciences Firms 4Health News:The SCOOTER Store Donates Power Wheelchair to Former Manassas Detective Stricken With Arthritis 2Health News:Synutra Provides Progress Update on Recall and Reports Results for the Second Quarter Ended September 30, 2008 2Health News:Synutra Provides Progress Update on Recall and Reports Results for the Second Quarter Ended September 30, 2008 3Health News:Synutra Provides Progress Update on Recall and Reports Results for the Second Quarter Ended September 30, 2008 4Health News:Synutra Provides Progress Update on Recall and Reports Results for the Second Quarter Ended September 30, 2008 5Health News:Synutra Provides Progress Update on Recall and Reports Results for the Second Quarter Ended September 30, 2008 6Health News:Lung Cancer Alliance Releases 4th Annual Report Card on Lung Cancer 2
(Date:12/4/2009)... 4 Depression, anxiety disorder, bipolar disorder, Attention ... These are among the comorbidities reported to occur ... been diagnosed with epilepsy versus those without an ... 173,000 households across the U.S. ,, Findings from ...
(Date:12/3/2009)... 3 A genetic variation that may indicate a ... if exposed to certain pharmaceutical therapies or chemicals is ... leader Quest Diagnostics (NYSE: DGX ) will ... Annual Meeting and Exposition, December 5-8, 2009, in New ...
(Date:12/3/2009)... leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities ... America in Chicago. The Connect.PACS(TM) ... its kind, is the latest release in the ... ,, (Photo: http://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
Breaking Medicine Technology:Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3CU Boulder study shows Maya intensively cultivated manioc 1 400 years ago 8862 1CU Boulder study shows Maya intensively cultivated manioc 1 400 years ago 8862 2CU Boulder study shows Maya intensively cultivated manioc 1 400 years ago 8862 3CU Boulder study shows Maya intensively cultivated manioc 1 400 years ago 8862 4Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 1Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 2Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 3Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 4Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 5Springer to publish Journal of Medicine and the Person 49086 1Springer to publish Journal of Medicine and the Person 49086 2
Bactron IV is designed for high volume, yet requires far less bench space than expected for its capacity and performance features....
... I is an ideal first ... use by smaller laboratories, it ... economical set-up station for larger ... of other Bactron models are ...
Designed for larger laboratories or research applications, the Concept 1000 boasts some very unique features....
... is a fast, automated system for ... of microaerophilic organisms.Designed for the cost ... runs at 1% of the cost ... suitable for growth of specimens such ...
Medicine Products: